Search results
Results from the WOW.Com Content Network
With paroxysmal nocturnal dyspnea specifically, it is felt while sleeping and causes a person to wake up after about 1 to 2 hours of sleep. [ 3 ] More serious forms of dyspnea can be identified through accompanying findings, such as low blood pressure, decreased respiratory rate, altered mental status, hypoxia, cyanosis, stridor, or unstable ...
Risk Factors for Sleep Apnea. There are several risk factors for sleep apnea. These include: Obesity. If you have excess weight or obesity, you may have more fat deposits in your neck that can put ...
The conditions of hypoxia and hypercapnia, whether caused by apnea or not, trigger additional effects on the body.The immediate effects of central sleep apnea on the body depend on how long the failure to breathe endures, how short is the interval between failures to breathe, and the presence or absence of independent conditions whose effects amplify those of an apneic episode.
A large analysis in 2019 of the estimated prevalence of OSA found that OSA affects 936 million—1 billion people between the ages of 30–69 globally, or roughly every 1 in 10 people, and up to 30% of the elderly. [28] Sleep apnea is somewhat more common in men than women, roughly a 2:1 ratio of men to women, and in general more people are ...
The man had sleep apnea—his airway was obstructed, which interrupted breathing at night, waking him repeatedly. But he refused Sullivan’s recommendation for surgery to create an opening in the ...
The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug Administration Dec. 20 press release.
As sleep time decreased over time from the 1950s to 2000s from about 8.5 hours to 6.5 hours, there has been an increase in the prevalence of obesity from about 10% to about 23%. [2] Weight gain itself may also lead to a lack of sleep as obesity can negatively affect quality of sleep, as well as increase risk of sleeping disorders such as sleep ...
Eli Lilly on Friday said its popular weight-loss drug Zepbound helped resolve moderate to severe obstructive sleep apnea in up to 52% of patients in two late-stage trials. U.S.-based Lilly and ...